Johnson & Johnson, ViiV Healthcare: Two injections every month or two could control HIV Pooja Bhatia Bhatia5 Nov 2015 9:07 AM ISTJohnson & Johnson and partner ViiV Healthcare, which specializes in HIV drugs, has recently shared results from the first 32 weeks of the...
GlaxoSmithKline to seek approval for 20 new medicines by 2020 Pooja Bhatia Bhatia4 Nov 2015 1:16 PM ISTBritish drugmaker GlaxoSmithKline has recently reported it strategy to boost its sales in the market, which in turn has been affected by the declining...
InSite Vision acquired by Sun Pharmaceutical Pooja Bhatia Bhatia4 Nov 2015 11:35 AM ISTDrug major Sun Pharmaceutical Industries has recently completed acquisition of the US-based eyecare firm InSite Vision.The acquisition was completed...
Lupin gets approval from FDA for generic drug for dementia Pooja Bhatia Bhatia4 Nov 2015 10:39 AM ISTUSFDA has recently given its approval to the pharma major Lupin to market generic Aricept tablets used for treatment of dementia.The company's US...
Biocon amongst the top Biopharma companies in a global survey Pooja Bhatia Bhatia4 Nov 2015 10:33 AM ISTBiocon Ltd, in a recent press report, has stated its achievement of earning the reputation and distinction of being the only Asian Biopharma company...
No fixation of price for 98 drugs identified by NPPA Pooja Bhatia Bhatia3 Nov 2015 10:55 AM ISTNPPA had earlier identified and prepared a list of fixing the price for 98 drugs used for treating various diseases such as such as tuberculosis,...
Dr Reddy’s Laboratories to launch pain relief spray in India Pooja Bhatia Bhatia3 Nov 2015 10:47 AM ISTDr Reddy's Laboratories is reported to have introduced a pain relief spray under 'Nise D Spray' in the Indian market. This initiative can be viewed as...
NPPA caps prices of 18 formulations packs including diabetes drugs Meghna A Singhania2 Nov 2015 11:39 AM ISTNPPA (National Pharmaceutical Pricing Authority) has recently put a cap on prices of 18 formulations packs. Under this recent development, the list of...
Sun Pharma to discontinue non-strategic business units Meghna A Singhania2 Nov 2015 11:08 AM ISTAs a part of its integration process with Ranbaxy Laboratories, Sun Pharma is likely to discontinue certain non-strategic businesses to have a smooth...
Glenmark gets tentative USFDA nod for Lacosamide tablets Meghna A Singhania30 Oct 2015 12:21 PM ISTGlenmark Pharmaceuticals today said it has received tentative approval from the US health regulator for its Lacosamide tablets."Glenmark...
Pfizer in merger talks with Botox-maker Allergan: Report Meghna A Singhania30 Oct 2015 10:50 AM ISTPharmaceutical giant Pfizer Inc recently approached Botox-maker Allergan Plc to discuss what could be the biggest takeover deal this year, the Wall...
Hilleman Lab to invest Rs 300 crore to develop vaccines Meghna A Singhania29 Oct 2015 12:54 PM ISTMumbai: Hilleman Laboratories today said it will invest around Rs 300 crore in the next 4-5 years to develop low-cost vaccines to treat diseases like...
